Concurrent alterations in the DCC and UNC5C genes were observed significantly more commonly in advanced stages (64 % (21/ 33) for stages III and IV) than in earlier-stage cancers (24 % (8/33) for stages I and II, P = 0.001, Pearson’s chi-square test; Fig. 4a). The gene discussed is DCC; the disease is cancer.